中风预防的当前及未来概念
Current and future concepts in stroke prevention.
作者信息
O'Rourke Fintan, Dean Naeem, Akhtar Naveed, Shuaib Ashfaq
机构信息
Stroke Prevention Clinic, University of Alberta Hospital, Mackenzie Health Sciences Centre.
出版信息
CMAJ. 2004 Mar 30;170(7):1123-33. doi: 10.1503/cmaj.1031185.
Abstract
Stroke is a major cause of morbidity and mortality in an aging population. The current understanding of the pathophysiology of atherosclerotic diseases, the most common cause of stroke, and the evidence for existing therapeutic interventions for the prevention of stroke are presented. Specifically, we review the evidence for antiplatelet agents, anticoagulants, antihypertensive medications, lipid-lowering agents and carotid endarterectomy for stroke prevention.
摘要
中风是老年人群发病和死亡的主要原因。本文介绍了对动脉粥样硬化性疾病（中风最常见的病因）病理生理学的当前认识以及现有预防中风治疗干预措施的证据。具体而言，我们综述了抗血小板药物、抗凝剂、抗高血压药物、降脂药物和颈动脉内膜切除术预防中风的证据。
相似文献
1
Current and future concepts in stroke prevention.中风预防的当前及未来概念
CMAJ. 2004 Mar 30;170(7):1123-33. doi: 10.1503/cmaj.1031185.
2
Stroke Prevention in Older Adults: Recent Advances.老年人脑卒中预防：最新进展。
Stroke. 2020 Dec;51(12):3770-3777. doi: 10.1161/STROKEAHA.120.031707. Epub 2020 Oct 30.
3
Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke.临床神经科学进展：中风二级预防的药物治疗
Can J Neurol Sci. 2004 Aug;31(3):295-303. doi: 10.1017/s0317167100003358.
4
[Prophylaxis of stroke].[中风的预防]
Praxis (Bern 1994). 2005 Jul 27;94(30-31):1171-3. doi: 10.1024/0369-8394.94.30.1171.
5
Stroke prevention in the high-risk patient.高危患者的卒中预防
Expert Opin Pharmacother. 2007 Aug;8(12):1851-9. doi: 10.1517/14656566.8.12.1851.
6
Stroke prevention.中风预防
Clin Evid. 2004 Dec(12):253-84.
7
Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.临床实践。缺血性中风或短暂性脑缺血发作后的二级预防。
N Engl J Med. 2012 May 17;366(20):1914-22. doi: 10.1056/NEJMcp1107281.
8
Drug treatments in the secondary prevention of ischaemic stroke.缺血性中风二级预防中的药物治疗。
Maturitas. 2013 Nov;76(3):267-71. doi: 10.1016/j.maturitas.2013.05.009. Epub 2013 Jun 12.
9
Controversies: Stroke Prevention in Chronic Kidney Disease.争议：慢性肾脏病的卒中预防。
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105679. doi: 10.1016/j.jstrokecerebrovasdis.2021.105679. Epub 2021 Feb 25.
10
How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?中风、短暂性脑缺血发作或颈动脉内膜切除术后的血管风险管理效果如何？
Cerebrovasc Dis. 2007;23(2-3):156-61. doi: 10.1159/000097053. Epub 2006 Nov 16.
引用本文的文献
1
A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine.中西医中与中风相关的信号通路及治疗的综合综述。
Front Neurosci. 2023 Jun 7;17:1200061. doi: 10.3389/fnins.2023.1200061. eCollection 2023.
2
A new cerebral ischemic injury model in rats, preventive effect of gallic acid and approaches.一种新的大鼠脑缺血损伤模型、没食子酸的预防作用及方法
Saudi J Biol Sci. 2021 Sep;28(9):5204-5213. doi: 10.1016/j.sjbs.2021.05.044. Epub 2021 May 24.
3
The Needs and Barriers of Medication-Taking Self-Efficacy Among Poststroke Patients: Qualitative Study.中风后患者服药自我效能的需求与障碍：定性研究
JMIR Nurs. 2019 Jul 22;2(1):e14399. doi: 10.2196/14399. eCollection 2019 Jan-Dec.
4
Exploring stroke survivors' self-efficacy in understanding and taking medication and determining associated factors: a cross-sectional study in a neurology clinic in Malaysia.探索中风幸存者在理解和服药方面的自我效能感及相关因素：马来西亚一家神经科诊所的横断面研究
Patient Prefer Adherence. 2019 Aug 28;13:1463-1475. doi: 10.2147/PPA.S215271. eCollection 2019.
5
RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.撤回：苯扎贝特改善线粒体脑病小鼠模型中枢神经系统中线粒体功能。
Mitochondrion. 2013 Sep;13(5):417-26. doi: 10.1016/j.mito.2012.12.003. Epub 2012 Dec 20.
6
Therapeutic Potential of PPARγ Activation in Stroke.过氧化物酶体增殖物激活受体γ 在脑卒中的治疗潜能。
PPAR Res. 2008;2008:461981. doi: 10.1155/2008/461981. Epub 2008 Apr 13.
7
Radiation dose from multidetector row CT imaging for acute stroke.多排螺旋CT成像在急性脑卒中诊断中的辐射剂量
Neuroradiology. 2009 Oct;51(10):635-40. doi: 10.1007/s00234-009-0543-6. Epub 2009 Jun 9.
8
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.过氧化物酶体增殖物激活受体γ激动剂的抗炎和神经保护作用机制。
Front Biosci. 2008 Jan 1;13:1813-26. doi: 10.2741/2802.
9
Stroke prevention.中风预防。
CMAJ. 2005 Aug 16;173(4):363. doi: 10.1503/cmaj.050860.
本文引用的文献
1
Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.非心源性栓塞性卒中患者的心房解剖结构：药物治疗的效果
J Am Coll Cardiol. 2003 Sep 17;42(6):1066-72. doi: 10.1016/s0735-1097(03)00907-0.
2
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.口服抗凝强度对心房颤动患者卒中严重程度及死亡率的影响。
N Engl J Med. 2003 Sep 11;349(11):1019-26. doi: 10.1056/NEJMoa022913.
3
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告：JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
4
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.老年人认知与预后研究（SCOPE）：一项随机双盲干预试验的主要结果
J Hypertens. 2003 May;21(5):875-86. doi: 10.1097/00004872-200305000-00011.
5
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.在盎格鲁-斯堪的纳维亚心脏结局试验——降脂分支（ASCOT-LLA）中，阿托伐他汀对胆固醇浓度处于平均水平或低于平均水平的高血压患者冠心病和中风事件的预防作用：一项多中心随机对照试验。
Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0.
6
Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients.卵圆孔未闭伴反常栓塞：256例患者经导管封堵的中期结果
J Interv Cardiol. 2003 Feb;16(1):43-50. doi: 10.1046/j.1540-8183.2003.08002.x.
7
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.降脂治疗对预防中风的差异效应：随机试验的荟萃分析
Arch Intern Med. 2003 Mar 24;163(6):669-76. doi: 10.1001/archinte.163.6.669.
8
Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors.血浆高敏C反应蛋白与传统心血管危险因素的关系。
Atherosclerosis. 2003 Mar;167(1):73-9. doi: 10.1016/s0021-9150(02)00380-5.
9
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.老年高血压患者使用血管紧张素转换酶抑制剂和利尿剂的疗效比较。
N Engl J Med. 2003 Feb 13;348(7):583-92. doi: 10.1056/NEJMoa021716.
10
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).美国心脏病学会/美国心脏协会慢性稳定型心绞痛患者管理指南2002年更新版——总结文章：美国心脏病学会/美国心脏协会实践指南特别工作组（慢性稳定型心绞痛患者管理委员会）报告
Circulation. 2003 Jan 7;107(1):149-58. doi: 10.1161/01.cir.0000047041.66447.29.
Zotero 插件